RxDoctor Payments Data

Joshua Vest

Foot & Ankle Surgery · Lincoln, NENPI 1235461294

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Stryker accounts for 95.5% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2023 at $13,343 and has fallen 98.1% since, to $258 in 2025.

$40,497in general payments, 2019–2025

Across 143 payments — averaging $283.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$39K
  • Musculoskeletal Transplant Foundation Inc.$284
  • Treace Medical Concepts, Inc.$256
  • DJO, LLC$159
  • Nevro Corp.$137
  • Orthofix Medical, Inc.$113
  • plus $888 from 24 others
$1,309in research payments, 2019–2025

Across 11 payments — averaging $119.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$1K

What the payments were for

  • Consulting fees$20,65051%
  • Speaking & faculty fees$9,60424%
  • Travel & lodging$5,33813%
  • Food & beverage$4,90512%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,497 in reported general payments places this provider in the 85th percentile of 43 foot & ankle surgery providers in Nebraska.

See all foot & ankle surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$108,968
Medicare patients
329
Services billed
965

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$258
Meloxicam15$76
Methylprednisolone13$72

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →